StockNews.com lowered shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a hold rating in a report published on Wednesday. A number of other equities analysts have also recently commented on PRTK. Jefferies Financial Group cut shares of Paratek Pharmaceuticals from a buy rating to a hold rating in a research […]